Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,450 | -591 | -4,808 | -7,292 | -1,116 |
| Depreciation Amortization | 197 | 276 | 960 | 698 | 901 |
| Income taxes - deferred | -457 | -475 | -3,255 | -69 | 75 |
| Accounts receivable | -1,181 | -1,027 | -3,057 | -5,365 | 386 |
| Accounts payable and accrued liabilities | 1,577 | -348 | 1,504 | 3,622 | 211 |
| Other Working Capital | -58 | -104 | -1,328 | -2,181 | -189 |
| Other Operating Activity | -440 | 1,526 | 8,056 | 7,822 | -401 |
| Operating Cash Flow | $-1,811 | $-742 | $-1,928 | $-2,764 | $-134 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -164 | N/A | N/A | N/A |
| PPE Investments | 4 | N/A | -800 | -124 | -187 |
| Net Acquisitions | N/A | N/A | N/A | -600 | N/A |
| Purchase Of Investment | -174 | N/A | -698 | N/A | N/A |
| Other Investing Activity | 337 | 230 | -684 | -261 | -331 |
| Investing Cash Flow | $166 | $66 | $-2,183 | $-985 | $-517 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -399 | -375 | 62 | 82 | -278 |
| Debt Issued | N/A | N/A | 2,000 | 1,924 | N/A |
| Debt Repayment | N/A | N/A | -688 | N/A | -688 |
| Common Stock Issued | 1,444 | 829 | 1,834 | 1,778 | 1,652 |
| Other Financing Activity | 140 | 0 | -288 | -73 | 182 |
| Financing Cash Flow | $1,186 | $454 | $2,920 | $3,711 | $868 |
| Exchange Rate Effect | 4 | -19 | -96 | -13 | 88 |
| Beginning Cash Position | 843 | 843 | 2,129 | 2,129 | 2,129 |
| End Cash Position | 388 | 602 | 843 | 2,080 | 2,435 |
| Net Cash Flow | $-455 | $-241 | $-1,286 | $-50 | $305 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,811 | -742 | -1,928 | -2,764 | -134 |
| Capital Expenditure | N/A | N/A | -1,264 | N/A | -187 |
| Free Cash Flow | -1,811 | -742 | -3,192 | -2,764 | -321 |